62 related articles for article (PubMed ID: 1664839)
1. [Ribonucleotide reductase--a "target" of the action of nitrosomethylurea].
Filatov DE; Kudriavtsev ME; Baĭder LM; Sharygin VL; Griakalov KV; Pulatova MK; Korman DB
Izv Akad Nauk SSSR Biol; 1991; (4):528-39. PubMed ID: 1664839
[TBL] [Abstract][Full Text] [Related]
2. [The EPR spectra of the ribonucleotide reductase in the tumorous tissues and organs of tumor-bearing animals].
Pulatova MK; Filatov DE; Sharygin VL; Gorbacheva LB; Gudtsova KV; Kuropteva ZV; Zhumabaeva TT; Shamaev VI; Korman DB
Izv Akad Nauk SSSR Biol; 1990; (5):737-48. PubMed ID: 2177066
[TBL] [Abstract][Full Text] [Related]
3. [Time- and dose-dependent post-irradiation changes of Fe3+-transferrin and Cu2+-ceruloplasmin pools in blood, their influence on ribonucleotide reductase activity in animal tissues and the effects of radioprotectors].
Sharygin VL; Pulatova MK; Shliakova TG; Todorov IN
Radiats Biol Radioecol; 2003; 43(6):662-77. PubMed ID: 14963934
[TBL] [Abstract][Full Text] [Related]
4. [The dose dependence of the development of compensatory-restorative body reactions to irradiation. The EPR method].
Pulatova MK; Filatov DE; Shliakova TG; Sharygin VL; Beletskiĭ VP; Chernov GA
Izv Akad Nauk SSSR Biol; 1992; (2):215-33. PubMed ID: 1331216
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
[TBL] [Abstract][Full Text] [Related]
6. [Changes in ribonucleotide reductase activity in mouse leukemic cells and spleen during in vivo tumor growth and hydroxyurea administration].
Gudtsova KV; Pulatova MK; Gorbacheva LB
Dokl Akad Nauk SSSR; 1987; 297(2):480-2. PubMed ID: 2827980
[No Abstract] [Full Text] [Related]
7. [Identification of electron spin resonance signals of ribonucleotide reductase in animal tissues with high proliferative activity].
Pulatova MK; Avakian MA; Sharygin VL
Biofizika; 1986; 31(2):340-2. PubMed ID: 3008860
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
Chitambar CR; Narasimhan J; Guy J; Sem DS; O'Brien WJ
Cancer Res; 1991 Nov; 51(22):6199-201. PubMed ID: 1933878
[TBL] [Abstract][Full Text] [Related]
9. [Liver aldolase as a possible target for the action of N-methyl-N-nitrosourea].
Treshchenkova IuA; Burlakova EB
Biokhimiia; 1989 Mar; 54(3):516-23. PubMed ID: 2752067
[TBL] [Abstract][Full Text] [Related]
10. [The effect of 3,4-disuccinyldianhydrogalactitol, N-nitrosourea and their combination on DNA synthesis in normal and mouse P388 tumor cells].
Sokolova IS; Veres Z; Jakus J; Otvos LL; Gorbacheva LB
Izv Akad Nauk SSSR Biol; 1989; (4):527-33. PubMed ID: 2794230
[TBL] [Abstract][Full Text] [Related]
11. [The radical enzyme ribonucleotide reductase in animal tissues with a high proliferative activity].
Pulatova MK; Avakian MA; Sharygin VL; Postnov LA; Bibikova AD
Izv Akad Nauk SSSR Biol; 1986; (5):721-6. PubMed ID: 3023468
[No Abstract] [Full Text] [Related]
12. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
[TBL] [Abstract][Full Text] [Related]
13. Loss of the tyrosyl radical in mouse ribonucleotide reductase by (-)-epicatechin.
Schroeder P; Voevodskaya N; Klotz LO; Brenneisen P; Gräslund A; Sies H
Biochem Biophys Res Commun; 2005 Jan; 326(3):614-7. PubMed ID: 15596143
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ribonucleotide reductase in thymocytes of rats treated by ditiocarb sodium.
Tempel K; Spath A; Stammberger I
Arzneimittelforschung; 1990 Jul; 40(7):787-90. PubMed ID: 1699544
[TBL] [Abstract][Full Text] [Related]
15. [The role of ribonucleotide reductase in the regulation of post-radiation DNA synthesis].
Pulatova MK; Sharygin VL; Filatov DE; Efremova OI; Todorov IN
Dokl Akad Nauk SSSR; 1988; 300(1):233-6. PubMed ID: 2843339
[No Abstract] [Full Text] [Related]
16. A diurnal variation in the tumorigenic response of mouse epidermis to a single application of the strong short-acting chemical carcinogen methylnitrosourea. A dose-response study of 1, 2 and 10 mg.
Iversen OH; Iversen UM
In Vivo; 1995; 9(2):117-32. PubMed ID: 7548787
[TBL] [Abstract][Full Text] [Related]
17. [A morphofunctional evaluation of the immunomodulating action of nitrosomethylurea].
Potapov IuN; Khaleev DV; Krutova TV
Eksp Klin Farmakol; 1995; 58(3):48-50. PubMed ID: 7663298
[TBL] [Abstract][Full Text] [Related]
18. Changes in de novo DNA (cytosine-5-)-methyltransferase activity in oncogenically susceptible rat target tissues induced by N-methyl-N-nitrosourea.
Pfohl-Leszkowicz A; Dirheimer G
Cancer Res; 1986 Mar; 46(3):1110-3. PubMed ID: 3943088
[TBL] [Abstract][Full Text] [Related]
19. Unexpected genetic toxicity to rodents of the N',N'-dimethyl analogues of MNU and ENU.
Tinwell H; Paton D; Guttenplan JB; Ashby J
Environ Mol Mutagen; 1996; 27(3):202-10. PubMed ID: 8625956
[TBL] [Abstract][Full Text] [Related]
20. [Effect of chloramphenicol on the toxic and therapeutic effect of N-nitrosomethylurea].
Bogush TA; Konopleva IA; Shabad LM
Vopr Onkol; 1977; 23(12):66-70. PubMed ID: 602081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
